What Is the Future of Cystoscopy for Detecting Urothelial Carcinoma?

No AccessJournal of UrologyEditorial7 Jun 2024What Is the Future of Cystoscopy for Detecting Urothelial Carcinoma? Christopher B. Anderson Christopher B. AndersonChristopher B. Anderson Assistant Editor, The Journal of Urology Department of Urology, Columbia University Irving Medical Center, New York, New York View All Author Informationhttps://doi.org/10.1097/JU.0000000000004071AboutFull TextPDF Cite Export CitationSelect Citation formatNLMIEEEACMAPAChicagoMLAHarvardTips on citation downloadDownload citationCopy citation ToolsAdd to favoritesTrack Citations ShareFacebookLinked InTwitterEmail "What Is the Future of Cystoscopy for Detecting Urothelial Carcinoma?." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. . Evaluation of the new American Urological Association guidelines risk classification for hematuria. J Urol.2021; 205(5):1387-1393. doi: 10.1097/JU.0000000000001550 Link, Google Scholar 2. . Disparities in the diagnostic evaluation of microhematuria and implications for the detection of urologic malignancy. Urol Oncol.2019; 37(5):300.e1-300.e7. doi: 10.1016/j.urolonc.2019.01.007 Crossref, Medline, Google Scholar 3. . A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma. BMC Urol.2015; 15:23. doi: 10.1186/s12894-015-0018-5 Crossref, Medline, Google Scholar 4. . Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy. N Z Med J.2019; 132(1497):55-64. Medline, Google Scholar 5. . Assessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopy. N Z Med J.2020; 133(1527):71-82. Medline, Google Scholar 6. . A multicenter prospective randomized controlled trial comparing Cxbladder triage to cystoscopy in patients with microhematuria. The safe testing of risk for asymptomatic microhematuria trial. J Urol. Published online May 3, 2024. doi: 10.1097/JU.0000000000003991 Link, Google Scholar 7. . A urine-based genomic assay improves risk stratification for patients with high-risk hematuria stratified according to the American Urological Association guidelines. Eur Urol Oncol.2023; 6(2):183-189. doi: 10.1016/j.euo.2022.08.002 Crossref, Medline, Google Scholar 8. . A urine based genomic assay to triage patients with hematuria for cystoscopy. J Urol.2020; 204(1):50-57. doi: 10.1097/JU.0000000000000786 Link, Google Scholar 9. . Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk-prediction. Clin Cancer Res.2023; 29(18):3668-3680. doi: 10.1158/1078-0432.CCR-23-0570 Crossref, Medline, Google Scholar 10. . Perception of urinary biomarker tests among patients referred with suspected urological malignancy. BJUI Compass.2023; 4(4):446-454. doi: 10.1002/bco2.234 Crossref, Medline, Google Scholar © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Peer Review Report Open Peer Review Report Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Christopher B. Anderson Assistant Editor, The Journal of Urology Department of Urology, Columbia University Irving Medical Center, New York, New York More articles by this author Expand All Advertisement PDF downloadLoading ...